Chinook Therapeutics Probability of Future Stock Price Finishing Under 20.01
Chinook Therapeutics' future price is the expected price of Chinook Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Chinook Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please specify Chinook Therapeutics' target price for which you would like Chinook Therapeutics odds to be computed.
Chinook |
Chinook Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Chinook Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Chinook Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Chinook Therapeutics is not yet fully synchronised with the market data | |
| Chinook Therapeutics has some characteristics of a very speculative penny stock | |
| Chinook Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.13 M. Net Loss for the year was (187.87 M) with loss before overhead, payroll, taxes, and interest of (135.08 M). | |
| Chinook Therapeutics currently holds about 362.61 M in cash with (117.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.76. | |
| Over 97.0% of the company shares are owned by institutional investors |
Chinook Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Chinook Stock often depends not only on the future outlook of the current and potential Chinook Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chinook Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 64.4 M | |
| Cash And Short Term Investments | 378.3 M |
Chinook Therapeutics Technical Analysis
Chinook Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Chinook Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Chinook Therapeutics. In general, you should focus on analyzing Chinook Stock price patterns and their correlations with different microeconomic environments and drivers.
Chinook Therapeutics Predictive Forecast Models
Chinook Therapeutics' time-series forecasting models is one of many Chinook Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Chinook Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Chinook Therapeutics
Checking the ongoing alerts about Chinook Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Chinook Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Chinook Therapeutics is not yet fully synchronised with the market data | |
| Chinook Therapeutics has some characteristics of a very speculative penny stock | |
| Chinook Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.13 M. Net Loss for the year was (187.87 M) with loss before overhead, payroll, taxes, and interest of (135.08 M). | |
| Chinook Therapeutics currently holds about 362.61 M in cash with (117.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.76. | |
| Over 97.0% of the company shares are owned by institutional investors |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Chinook Stock
If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world |